Home > PE Ratio > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of AAREY DRUGS & PHARMACEUTICALS is 50.86.

Share Price ₹81.0Jun 10,2026
Market Cap ₹230.0 Cr
Earnings-TTM₹4.5 CrTTM-Standalone Results
Price/Earnings50.86xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of AAREY DRUGS & PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of AAREY DRUGS & PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹230.0 Cr] as on Jun 10,2026

(/) Earnings [ ₹4.5 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 50.86x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for AAREY DRUGS & PHARMACEUTICALS , the investors are currently willing to pay 50.86 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AAREY DRUGS & PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of AAREY DRUGS & PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of AAREY DRUGS & PHARMACEUTICALS


PE Ratio Performance Analysis for AAREY DRUGS & PHARMACEUTICALS

- AAREY DRUGS & PHARMACEUTICALS 's latest p/e ratio is 50.86x.

- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 18.18x.

- AAREY DRUGS & PHARMACEUTICALS 's operated at median p/e ratio of 16.03x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AAREY DRUGS & PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 26.76x.

- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 8.33x.


How does AAREY DRUGS & PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Earnings-TTM (Cr)PE RatioMarket Cap
AAREY DRUGS & PHARMACEUTICALS 4.5250.86230.0
ADANI ENTERPRISES LTD9,693.5139.35381,403.0
PREMIER ENERGIES LTD1,504.5732.1348,348.1
ADITYA INFOTECH LTD367.96110.0740,501.1
AEGIS LOGISTICS LTD1,106.6325.4028,108.1
REDINGTON LTD1,284.1514.0017,973.0
RRP SEMICONDUCTOR LTD-7.75-1,610.6312,488.8
HONASA CONSUMER LTD200.3367.2213,467.1
LLOYDS ENTERPRISES LTD374.5327.1410,163.8
MMTC LTD212.0745.819,714.0
CELLO WORLD LTD331.5125.128,327.4

Trading Industry Benchmark (Top 10) PE Analysis vs AAREY DRUGS & PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -1,610.63x
Max industry PE 110.07x
Median industry PE 32.13x
Average industry PE -106.68x



You may also like the below Video Courses